1.2500
-0.0500
(-3.85%)
At close: January 10 at 3:59:59 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-25,244.0000
-28,448.0000
-23,355.0000
-22,433.0000
-22,068.0000
Investing Cash Flow
-236.0000
20,222.0000
-20,403.0000
-286.0000
-29.0000
Financing Cash Flow
5,039.0000
31,994.0000
12,205.0000
33,015.0000
39,773.0000
End Cash Position
19,540.0000
34,912.0000
11,666.0000
41,262.0000
31,220.0000
Income Tax Paid Supplemental Data
--
120.0000
46.0000
35.0000
12.0000
Capital Expenditure
-236.0000
-8.0000
-55.0000
-286.0000
-29.0000
Issuance of Capital Stock
4,951.0000
31,620.0000
12,574.0000
32,912.0000
38,296.0000
Repayment of Debt
-352.0000
-407.0000
-381.0000
-366.0000
-461.0000
Free Cash Flow
-25,480.0000
-28,456.0000
-23,410.0000
-22,719.0000
-22,097.0000
12/31/2020 - 6/1/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TH.TO Theratechnologies Inc.
2.6900
-7.88%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
MDNA.TO Medicenna Therapeutics Corp.
1.3700
-5.52%
APS.TO Aptose Biosciences Inc.
0.3150
+1.61%
ONCO.CN Onco-Innova
1.2000
0.00%
ONC BeiGene, Ltd.
176.71
-0.66%
EPRX.TO Eupraxia Pharmaceuticals Inc.
4.3200
-0.23%
MSCL.TO Satellos Bioscience Inc.
0.8500
+1.19%
MBX.TO Microbix Biosystems Inc.
0.4200
+1.20%
SVA.TO Sernova Corp.
0.2250
0.00%